A. Leigh Corbett
Promotes COO Lefteris To Top Post
UCI Health said Chad Lefteris is taking on the role of chief executive effective immediately. His new appointment will allow his supervision to cover UCI’s academic medical center and all the clinical and patient operations of Orange County’s largest hospital.
Fujifilm’s Drug Tests Well on Coronavirus
The parent company of Santa Ana-based Fujifilm Irvine Scientific may have a treatment for the coronavirus.
Touts Product To Reduce Eyestrain
Costa Mesa-based Neurolens Inc., which is trying to reduce the problem of eyestrain from viewing digital devices, disclosed it has raised $23.8 million, according to a March 12 filing with the Securities and Exchange Commission.
Irvine Maker’s MaxAir System in High Demand
Irvine-based Bio-Medical Devices International Inc. is seeing increasing demand for its purifying respirator MaxAir Systems to fight the coronavirus.
Clot-Retrieval Device Moves to Trials
Irvine-based NeuroVasc Technologies Inc. raised $34 million from China-based Wego Group to support the company’s global clinical trial program for ischemic stroke.
New Irvine Office Runs 4,500 SF
NowRX raised over $10 million last month from small investors using SeedInvest to help with its expansion in Southern California, including its Irvine office.
Cites Positive Response To New Spine TV Device
Irvine-based Viseon Inc., an orthopedic spine technology company, has secured $18 million in Series B funding to bring its product into full commercialization.
Says ClearPoint Neuro Reflects Evolution
Irvine-based ClearPoint Neuro Inc. has changed its name from MRI Interventions and has a Nasdaq ticker symbol “CLPT.”
Says Ulcer Detector Ready for Market
Irvine-based Modulim says it is on the cusp of changing the lives of diabetic patients.
Anti-Aging Product Big Hit in Japan
Irvine-based Aivita Biomedical Inc., a biotech company specializing in stem cell applications for various uses, closed a Series B2 round of funding for $12.5 million.
Mayo Clinic, Columbia University to Study
Newport Beach-based ImmunogenX LLC, an early-stage drug developer, earlier this month said it began patient enrollment for its Phase 2b clinical trial for its treatment of celiac disease, an incurable digestive ailment that destroys the lining of the intestines.
OC’s Growing Hub for Cancer Care, Research, Funding
$1 billion is just the beginning.
Cousins a Vet Of IPOs, M&As
Irvine-based Inbrace, a maker of “invisible braces” which said it had record sales and raised $45 million in Series C funding, has named Kevin Cousins chief financial officer.
DetermaRx Test Used For Lung Cancer Treatment
The recently opened Judi and Bill Leonard Institute for Cancer Prevention, Treatment and Wellness at Mission Hospital in Mission Viejo has announced a partnership with new Orange County public company OncoCyte Corp. to use its product DetermaRx.
Firms Seeking Support At Emerging Summit
Sometimes, you can’t tell the medtech players without a scorecard.
A number of teams, most from out of the area, are sending players to Dana Point this week to talk medtech.
31 Facilities; $9.1 Billion; A Few Double-Digit Swings
To say hospitals are stable is a good thing, especially for people spending time there.
CEO Says Gov’t Backing Validates Progress
Anaheim-based BioCorRx Inc., a thinly traded small-cap stock, claims it’s developing a novel approach to treating opioid addiction.
OC’s No. 3 Device Maker by Size
Irvine-based Glidewell Dental Laboratories celebrated its 50th anniversary mid-January “with a relatively humble employee celebration,” according to press release.
HEALTHCARE: CEO moves, Irvine ops remain
Cryoport Inc., the fast-growing provider of cold-chain logistics services for the biopharmaceutical industry, is the latest local company to move its headquarters to the area around Nashville, Tenn.
Rancho Mission Viejo Health Site Runs 26K SF
It’s not just housing that’s growing in the South County master-planned community of Rancho Mission Viejo.
Can Move Quickly Into Clinical Trials
Irvine-based JenaValve Technology Inc. crossed a major hurdle when its transcatheter aortic valve replacement (TAVR) device for severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease was declared a “breakthrough device” by the Food and Drug Administration.
MEDTECH: Root canal alternative eyes expansion
From the guys who brought OC Glaukos
Analysts Expect 25% Sales Growth in 2020
Tustin-based contract drugmaker Avid Bioservices Inc. named Timothy Compton chief commercial officer this month.
Soon-Shiong Praises Co. As ‘Best’ of Type
Masimo Corp. (Nasdaq: MASI), the Irvine-based maker of noninvasive medical monitoring equipment, will purchase the assets of Culver City-based NantHealth’s Connected Care business for $47.3 million cash.
EDUCATION: New initiative emphasizes multi-disciplines
University of California-Irvine in 1964 was the first department of neuroscience in the U.S., which meant it was first to be studying the brain in an academic setting.
FDA Nod; Ex-Parent Sells for Up to $100M+
Irvine-based medical device maker Viseon Inc. is getting closer to commercializing its first product, which helps doctors better visualize the spine during surgery to that part of the body.
$300M Loan; FDA Progress for 2020
Urovant Sciences Ltd. (Nasdaq: UROV), which is developing medications to treat urologic issues, is starting the year with a new main investor from Japan, a $300 million loan, and progress in getting its core drug, vibegron, to market in the U.S.
First Such Artery Imaging Device for Japan
Aliso Viejo-based CathWorks, a medical device maker that provides 3D imaging of the coronary artery branch, announced in December the approval of its FFRangio system by Japan’s Ministry of Health, Labour and Welfare.